- Home
- EYEN vs KLTO Comparison
EYEN vs KLTO Comparison
Compare EYEN & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- KLTO
- Stock Information
- Founded
- EYEN 2014
- KLTO 2019
- Country
- EYEN United States
- KLTO United States
- Employees
- EYEN N/A
- KLTO N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- KLTO
- Sector
- EYEN Health Care
- KLTO
- Exchange
- EYEN Nasdaq
- KLTO NYSE
- Market Cap
- EYEN 9.2M
- KLTO 8.3M
- IPO Year
- EYEN 2018
- KLTO N/A
- Fundamental
- Price
- EYEN $0.06
- KLTO $0.41
- Analyst Decision
- EYEN Hold
- KLTO
- Analyst Count
- EYEN 4
- KLTO 0
- Target Price
- EYEN $2.00
- KLTO N/A
- AVG Volume (30 Days)
- EYEN 49.5M
- KLTO 1.4M
- Earning Date
- EYEN 11-12-2024
- KLTO 02-15-2025
- Dividend Yield
- EYEN N/A
- KLTO N/A
- EPS Growth
- EYEN N/A
- KLTO N/A
- EPS
- EYEN N/A
- KLTO N/A
- Revenue
- EYEN $31,832.00
- KLTO N/A
- Revenue This Year
- EYEN $23,413.60
- KLTO N/A
- Revenue Next Year
- EYEN $400.98
- KLTO N/A
- P/E Ratio
- EYEN N/A
- KLTO N/A
- Revenue Growth
- EYEN 2557.10
- KLTO N/A
- 52 Week Low
- EYEN $0.06
- KLTO $0.26
- 52 Week High
- EYEN $2.57
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- EYEN 35.58
- KLTO N/A
- Support Level
- EYEN $0.06
- KLTO N/A
- Resistance Level
- EYEN $0.09
- KLTO N/A
- Average True Range (ATR)
- EYEN 0.03
- KLTO 0.00
- MACD
- EYEN 0.00
- KLTO 0.00
- Stochastic Oscillator
- EYEN 1.58
- KLTO 0.00
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.